扶正抗痨方联合四联疗法治疗气阴两虚型肺结核临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R521

基金项目:


Clinical Study on Fuzheng Kanglao Prescription Combined with Quadruple Chemother⁃ apy for Pulmonary Tuberculosis of Deficiency of Both Qi and Yin Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察扶正抗痨方联合四联疗法治疗气阴两虚型肺结核的临床疗效。方法:选取112 例气阴两虚型肺结核患者作为研究对象,按随机数字表法分为对照组50 例及观察组62 例,对照组给予常规四联疗法进行抗结核治疗,观察组在对照组基础上加用扶正抗痨方口服,2 组均连续服用4 周。比较2 组临床疗效,比较2 组治疗前后中医证候评分及炎性因子[血清白细胞介素-6(IL-6)、白细胞介素-10(IL-10)、肿瘤坏死因子-α(TNF-α)]、T 细胞亚群指标的变化。结果:观察组临床疗效总有效率为90.32%,对照组总有效率为76.00%,2 组比较,差异有统计学意义(P<0.05)。治疗后,2 组中医证候主症评分、次症评分及总积分均较治疗前下降(P<0.05),观察组中医证候主症评分、次症评分及总积分均低于对照组,差异均有统计学意义(P<0.05)。治疗后,2 组血清IL-6、TNF-α 水平均较治疗前下降,IL-10 水平均较治疗前上升,差异均有统计学意义(P<0.05);治疗后,观察组血清IL-6,TNF-α 水平均低于对照组,IL-10 水平高于对照组,差异均有统计学意义(P<0.05)。治疗后,2 组CD8+水平均较治疗前下降,CD4+、CD4+/CD8+水平均较治疗前上升,差异均有统计学意义(P<0.05);观察组CD8+水平低于对照组,CD4+、CD4+/CD8+水平均高于对照组,差异均有统计学意义(P<0.05)。结论:扶正抗痨方联合四联疗法可有效减轻气阴两虚型肺结核患者的临床症状,提高疗效,减轻炎症反应。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Fuzheng Kanglao prescription combined with quadruple chemotherapy for pulmonary tuberculosis of deficiency of both qi and yin type. Methods:A total of 112 cases of patients with pulmonary tuberculosis of deficiency of both qi and yin type were selected as the study subjects and divided into the control group and the observation group according to the random number table method, with 50 and 62 cases in each group respectively. The control group was treated with routine quadruple chemotherapy for anti- tuberculosis treatment, and the observation group was additionally given oral administration of Fuzheng Kanglao prescription based on the treatment of the control group. Both groups were treated for four weeks. The changes in Chinese medicine syndrome scores,inflammatory factors in serum including interleukin- 6(IL- 6), interleukin- 10(IL- 10) and tumor necrosis factor- α(TNF- α), and T cell subsets indexes before and after treatment,and the clinical effects in the two groups were compared. Results:The total effective rate of clinical effect was 90.32% in the observation group and 76.00% in the control group,the difference being significant(P<0.05). After treatment,the scores of main symptoms and secondary symptoms and the total scores in Chinese medicine syndromes in the two groups were decreased when compared with those before treatment(P<0.05), and the scores of main symptoms and secondary symptoms and the total score in Chinese medicine syndromes in the observation group were lower than those in the control group,differences being significant(P<0.05). After treatment,the levels of IL-6 and TNF-α in serum in the two groups were decreased when compared with those before treatment,and the IL-10 levels were increased, differences being significant(P<0.05). After treatment, the levels of IL- 6 and TNF- α in serum in the observation group were lower than those in the control group,and the IL-10 level was higher,differences being significant (P<0.05). After treatment,the levels of CD8+ in the two groups were decreased compared with those before treatment,and the levels of CD4 + and CD4 +/CD8 + were increased compared with those before treatment,differences being significant (P< 0.05).The level of CD8+ in the observation group was lower than that in the control group, and the levels of CD4+ and CD4+/ CD8+ in the observation group were higher than those in the control group,differences being significant(P<0.05). Conclusion: Fuzheng Kanglao prescription combined with quadruple chemotherapy for pulmonary tuberculosis of deficiency of both qi and yin type can effectively relieve clinical symptoms and inflammatory responses,and improve the curative effect.

    参考文献
    相似文献
    引证文献
引用本文

徐婧,武喜明,赵娣.扶正抗痨方联合四联疗法治疗气阴两虚型肺结核临床研究[J].新中医,2022,54(11):102-106

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-06-10
  • 出版日期: